Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Investigational New Drugs|September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Investigational New Drugs|October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2020
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal CancerRichard D Kim, Nilofer S Azad, Michael A Morse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract CancerAmanda N Ruggieri, Mark Yarchoan, Subir Goyal, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2015
Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusionT N Machuca, O Mercier, S Collaud, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancerJoseph M Herman, Amol K Narang, Kent A Griffith, et al.
Pageof 23